sellWeak cluster of 3
Abell Alexander I. sold $323k of RPC
other at P10, Inc.. 25,000 shares at an average of $12.94, traded Dec 26, 2024, filed Dec 30, 2024.
Warning score
37Value
$323k
25,000 shares
Holdings after
325,000
-7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-141187, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 26, 2024 | SOpen-market sale Class A Common Stock | -25,000 | $12.94 | $323k | 325,000 | Dec 30, 2024 |
Related signals
Other insiders at P10, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 21Weak | sell | RPC P10, Inc. | Abell Alexander I. other | $246k | 20,000 | |
| 56Moderate | sell 3 | RPC P10, Inc. | McCoy David M. director, other | $707k | 55,545 | |
| 67Notable | sell 3 | RPC P10, Inc. | 210 Capital, LLC See Remarks | $663k | 50,000 | |
| 72Notable | sell 3 | RPC P10, Inc. | 210 Capital, LLC See Remarks | $2.0M | 150,000 | |
| 72Notable | sell 3 | RPC P10, Inc. | 210 Capital, LLC See Remarks | $7.7M | 575,000 | |
| 65Notable | sell 2 | RPC P10, Inc. | 210 Capital, LLC See Remarks | $6.0M | 438,500 | |
| 55Moderate | sell 2 | RPC P10, Inc. | 210 Capital, LLC See Remarks | $14M | 986,500 | |
| 64Notable | sell 3 | RPC P10, Inc. | Poston Edwin A. director, other | $288k | 20,724 | |
| 72Notable | sell 3 | RPC P10, Inc. | 210 Capital, LLC See Remarks | $33M | 2,339,028 | |
| 71Notable | sell 3 | RPC P10, Inc. | Poston Edwin A. director, other | $737k | 54,103 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.